These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2861567)

  • 21. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
    Waid TH; Lucas BA; Amlot P; Janossy G; Yacoub M; Cammisuli S; Jezek D; Rhoades J; Brown S; Thompson JS
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):61-70. PubMed ID: 2479265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.
    Thistlethwaite JR; Cosimi AB; Delmonico FL; Rubin RH; Talkoff-Rubin N; Nelson PW; Fang L; Russell PS
    Transplantation; 1984 Dec; 38(6):695-701. PubMed ID: 6390834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent.
    Vigeral P; Chkoff N; Chatenoud L; Campos H; Lacombe M; Droz D; Goldstein G; Bach JF; Kreis H
    Transplantation; 1986 Jun; 41(6):730-3. PubMed ID: 3520988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Minnesota antilymphocyte globulin and OKT3 for induction of immunosuppression in renal transplant patients.
    Light JA; Khawand N; Ali A; Brems W; Aquino A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1738-40. PubMed ID: 2652569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
    Goldstein G; Norman DJ; Shield CF; Kreis H; Burdick J; Flye MW; Rivolta E; Starzl T; Monaco A
    Prog Clin Biol Res; 1986; 224():239-49. PubMed ID: 3540993
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymphocyte function in patients treated with monoclonal anti-T3 antibody for acute cadaveric renal allograft rejection.
    Bowen A; Edwards LC; Gailiunas P; Helderman JH
    Transplantation; 1984 Nov; 38(5):489-93. PubMed ID: 6388070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients.
    Waid TH; Lucas BA; Thompson JS; Brown SA; Munch L; Prebeck RJ; Jezek D
    Transplantation; 1992 Jan; 53(1):80-6. PubMed ID: 1531095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OKT3 rescue therapy in pancreas-allograft rejection.
    Stratta RJ; Sollinger HW; D'Alessandro AM; Pirsch JD; Kalayoglu M; Belzer FO
    Diabetes; 1989 Jan; 38 Suppl 1():74-8. PubMed ID: 2521330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reuse of OKT3 after previous rejection or induction therapy in cadaveric renal transplantation.
    Shield CF; Hughes JD
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):35-8. PubMed ID: 2510509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation.
    Oh CS; Stratta RJ; Fox BC; Sollinger HW; Belzer FO; Maki DG
    Transplantation; 1988 Jan; 45(1):68-73. PubMed ID: 3276066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ; Benvenisty AI; Cianci J; Hardy MA
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quadruple immunosuppression: comparison of OKT3 and Minnesota antilymphocyte globulin.
    Light JA; Khawand N; Aquino A; Ali A; Korb S
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):10-3. PubMed ID: 2510505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
    Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report.
    Gilbert EM; Renlund DG; O'Connell JB; Eiswirth CC; Rothstein G; Gay WA; Bristow MR
    J Heart Transplant; 1987; 6(6):369-74. PubMed ID: 3320307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reexposure to OKT3 in renal allograft recipients.
    Mayes JT; Thistlethwaite JR; Stuart JK; Buckingham MR; Stuart FP
    Transplantation; 1988 Feb; 45(2):349-53. PubMed ID: 3278428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OKT3 monoclonal antibody reversal of renal and hepatic rejection in pediatric patients.
    Goldstein G; Kremer AB; Barnes L; Hirsch RL
    J Pediatr; 1987 Dec; 111(6 Pt 2):1046-50. PubMed ID: 3316579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction.
    Delmonico FL; Auchincloss H; Rubin RH; Russell PS; Tolkoff-Rubin N; Fang LT; Cosimi AB
    Ann Surg; 1987 Nov; 206(5):649-54. PubMed ID: 3314751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody (OKT3) rescue in refractory acute renal allograft rejection: report of 3 cases.
    Suvanapha R; Laorpatanaskul S; Vajaraphongse R; Kitisin P; Srivatanawongsa V; Mulikamas S; Vajaraphongse K; Boonvisut S; Chusil S; Panmuong W
    J Med Assoc Thai; 1989 Dec; 72(12):708-13. PubMed ID: 2628539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ; First MR; Mansour ME; Alexander JW; Penn I
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with OKT3 in vascularized pancreas transplantation.
    Sollinger HW; Stratta RJ
    Am J Kidney Dis; 1988 Feb; 11(2):145-8. PubMed ID: 3277405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.